160 related articles for article (PubMed ID: 37849559)
1. Novel Pyrazolopyrazine Compounds as SHP2 Inhibitors for Treating Glioblastoma.
Sabnis RW
ACS Med Chem Lett; 2023 Oct; 14(10):1336-1337. PubMed ID: 37849559
[TBL] [Abstract][Full Text] [Related]
2. Data-Driven Computational Modeling Identifies Determinants of Glioblastoma Response to SHP2 Inhibition.
Day EK; Zhong Q; Purow B; Lazzara MJ
Cancer Res; 2021 Apr; 81(8):2056-2070. PubMed ID: 33574084
[TBL] [Abstract][Full Text] [Related]
3. Novel Compounds as TEAD Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Sep; 14(9):1152-1153. PubMed ID: 37736181
[TBL] [Abstract][Full Text] [Related]
4. Novel Indazole Compounds as TEAD Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Oct; 14(10):1334-1335. PubMed ID: 37849539
[TBL] [Abstract][Full Text] [Related]
5. Novel Pyrazoloquinoline Compounds as KRAS Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Aug; 14(8):1045-1046. PubMed ID: 37583830
[TBL] [Abstract][Full Text] [Related]
6. Novel Quinoline Compounds as KRAS Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Jun; 14(6):707-708. PubMed ID: 37312857
[TBL] [Abstract][Full Text] [Related]
7. Novel Tricyclic Compounds as KRAS Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 May; 14(5):555-556. PubMed ID: 37197476
[TBL] [Abstract][Full Text] [Related]
8. Novel Fused Triazole Compounds as RIPK1 Inhibitors for Treating Neurodegenerative, Autoimmune, and Inflammatory Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Feb; 15(2):177-178. PubMed ID: 38352847
[TBL] [Abstract][Full Text] [Related]
9. Novel Phosphorylpurinone Compounds for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 Apr; 15(4):441-442. PubMed ID: 38628787
[TBL] [Abstract][Full Text] [Related]
10. Novel IL4I1 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Jun; 14(6):700-701. PubMed ID: 37312856
[TBL] [Abstract][Full Text] [Related]
11. Novel PARP7 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Dec; 14(12):1615-1616. PubMed ID: 38116422
[TBL] [Abstract][Full Text] [Related]
12. Novel PARP1 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2023 Dec; 14(12):1629-1630. PubMed ID: 38116419
[TBL] [Abstract][Full Text] [Related]
13. Novel PARP1 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 Feb; 15(2):161-162. PubMed ID: 38352834
[TBL] [Abstract][Full Text] [Related]
14. Novel ACC Inhibitors for Treating Acne.
Sabnis RW
ACS Med Chem Lett; 2024 Apr; 15(4):445-446. PubMed ID: 38628789
[TBL] [Abstract][Full Text] [Related]
15. Nitrogen-Containing 2,3-Dihydroquinazolinone Compounds as Na
Sabnis RW
ACS Med Chem Lett; 2023 Jul; 14(7):893-894. PubMed ID: 37465303
[TBL] [Abstract][Full Text] [Related]
16. Fused Bicyclic Heteroaryl Compounds as NLRP3 Inhibitors for Treating Asthma or COPD.
Sabnis RW
ACS Med Chem Lett; 2023 Jul; 14(7):895-896. PubMed ID: 37465294
[TBL] [Abstract][Full Text] [Related]
17. Novel CD73 Inhibitors for Treating Cancer.
Sabnis RW
ACS Med Chem Lett; 2024 May; 15(5):571-572. PubMed ID: 38746902
[TBL] [Abstract][Full Text] [Related]
18. Small-Molecule Inhibitors of Shp2 Phosphatase as Potential Chemotherapeutic Agents for Glioblastoma: A Minireview.
Mitra R; Ayyannan SR
ChemMedChem; 2021 Mar; 16(5):777-787. PubMed ID: 33210828
[TBL] [Abstract][Full Text] [Related]
19. Novel PCSK9 Inhibitors for Treating Cardiovascular Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Apr; 15(4):443-444. PubMed ID: 38628783
[TBL] [Abstract][Full Text] [Related]
20. Novel Heterocyclic PAD4 Inhibitors for Treating Diseases.
Sabnis RW
ACS Med Chem Lett; 2024 Mar; 15(3):340-341. PubMed ID: 38505857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
